Form 6-K ERICSSON LM TELEPHONE For: Aug 17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM 6-KREPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934For the month of August 2026Commission File Number 000-12033LM ERICSSON TELEPHONE COMPANY(Translation of registrant’s name into English)Torshamnsgatan 21, KistaSE-164 83, Stockholm, Sweden(Address of principal executive offices)Indicate by check mark whether the registrant files or... (continue reading...)
Form 13F-HR CAPSTONE INVESTMENT ADVI For: Jun 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form 8-K EyePoint, Inc. For: Aug 17
false000131410200013141022026-08-172026-08-17
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 17, 2026
EyePoint, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware
000-51122
... (continue reading...)
Form 424B2 Corebridge Financial,
The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.Filed Pursuant to Rule 424(b)(2)Registration No. 333-275890 Subject to CompletionPreliminary Prospectus Supplement, dated August 17,... (continue reading...)
Form 13F-HR LITTLEJOHN & CO LLC For: Jun 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B5 BOSTON PROPERTIES LTD
-
Form N-PX Taylor Financial Group, For: Jun 30
-
Form 8-K BITMINE IMMERSION TECHNO For: Aug 17
-
Form S-3ASR LITHIUM AMERICAS CORP.
-
Form 424B5 SOUTHERN CALIFORNIA GAS
-
Form 497K Tidal Trust II
-
Form 424B5 Evergy, Inc.
-
Form 8-K AMASS BRANDS For: Aug 17
-
Form N-PX Keudell/Morrison Wealth For: Jun 30
-
Form 485BXT Investment Managers Seri
-
Form 8-K NVIDIA CORP For: Aug 17
-
Form 6-K Nasus Pharma Ltd For: Jun 30
-
Form 485BXT Investment Managers Seri
-
Form 13F-HR AtlasMark Financial, For: Jun 30
-
Form D West Street Capital Part
-
Form 485BXT Investment Managers Seri
-
Form 424B2 Blue Owl Technology Fina
-
Form 8-K Corebridge Financial, For: Aug 17
-
Form 4 SIMILARWEB LTD. For: Aug 13 Filed by: Offer Or
-
Form D/A Valqevia Digital Markets
-
Form DEFA14A BLUE RIDGE BANKSHARES,
-
Form 424B3 Ameren Illinois Co
-
Form 8-K TMC the metals Co Inc. For: Aug 17
-
Form D/A EPOCH CAPITAL US FEEDER
-
Form 8-K BLUE RIDGE BANKSHARES, For: Aug 16
-
Form 8-K INVO Fertility, Inc. For: Aug 17
-
Form 8-K Dare Bioscience, Inc. For: Aug 14
-
Form 13F-HR Triton Financial Group For: Jun 30
-
Form 8-K Axe Compute Inc. For: Aug 17
-
Form 8-K Profound Medical Corp. For: Aug 17
-
Form 4 Nayax Ltd. For: Aug 13 Filed by: Havshush Eran
-
Form D/A EPOCH CAPITAL OFFSHORE
-
Form 497VPU DELAWARE LIFE VARIABLE
-
Form 425 Fulcrum Therapeutics, Filed by: Fulcrum Therapeutics, Inc.
-
Form 425 BLUE RIDGE BANKSHARES, Filed by: HomeTrust Bancshares, Inc.
-
Form NT 10-Q SPLASH BEVERAGE GROUP, For: Jun 30
-
Form 8-K HomeTrust Bancshares, For: Aug 16
-
Form 6-K TRINITY BIOTECH PLC For: Aug 17
-
Form 425 Fulcrum Therapeutics, Filed by: Fulcrum Therapeutics, Inc.
-
Form D/A EPOCH CAPITAL US FEEDER
-
Form 4 CAMTEK LTD For: Aug 13 Filed by: Andorn Karni Yarl
-
Form 8-K HANMI FINANCIAL CORP For: Aug 17
-
Form 8-K Dermata Therapeutics, For: Aug 16
-
Form 8-K CREDITRISKMONITOR COM For: Aug 12
-
Form 8-K ABUNDIA GLOBAL IMPACT For: Aug 15
-
Form 424B5 Dare Bioscience, Inc.
-
Form 8-K Fulcrum Therapeutics, For: Aug 16
-
Form NT 10-Q FutureTech II Acquisitio For: Jun 30
-
Form 4 ACCESS Newswire Inc. For: Aug 14 Filed by: Pollard Wesley T
-
Form 4 Aclarion, Inc. For: Aug 13 Filed by: Wesemann William
